NOVEL HUMAN POLYPEPTIDES ENCODED BY POLYNUCLEOTIDES

Details for Australian Patent Application No. 2003274935 (hide)

Event Publications

12 February 2004 Complete Application Filed

Priority application(s): 60/410,953 17.09.02 US; 60/410,957 17.09.02 US; 60/411,037 17.09.02 US; 60/410,951 17.09.02 US; 60/410,946 17.09.02 US; 60/410,960 17.09.02 US; 60/411,111 17.09.02 US; 60/411,052 17.09.02 US; 60/406,616 29.08.02 US; 60/406,655 29.08.02 US; 60/406,640 29.08.02 US; 60/406,576 29.08.02 US; 60/406,666 29.08.02 US; 60/406,611 29.08.02 US; 60/406,612 29.08.02 US; 60/411,019 17.09.02 US; 60/411,024 17.09.02 US; 60/411,046 17.09.02 US; 60/411,082 17.09.02 US; 60/411,022 17.09.02 US; 60/410,962 17.09.02 US

6 May 2004 Application Open to Public Inspection

Published as AU-A-2003274935

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name FIVE PRIME THERAPEUTICS, INC., Application No. 2003274935, under INID (71) correct the name to read RIKEN The Institute of Physical and Chemical Research; KABUSHIKI KAISHA DNAFORM; FIVE PRIME THERAPEUTICS, INC. Corrigenda

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.